Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants

被引:75
作者
Lopez-Ganzalez, MA
Guerrero, JM
Rojas, F
Delgado, F
机构
[1] Virgen Rocio Univ, Unit Pediat Otorhinolaryngol, Infantile Hosp, E-41013 Seville, Spain
[2] Univ Seville, Sch Med, Dept Med Biochem & Mol Biol, E-41009 Seville, Spain
[3] Virgen Macarena Hosp, Seville, Spain
关键词
antioxidants; cisplatin; distortion products; melatonin; otoacoustic emmisions; ototoxicity; outer hair cells; pineal gland;
D O I
10.1034/j.1600-079X.2001.280202.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanism of the ototoxicity caused by cisplatin is based in the generation of reactive oxygen species, which interferes with the antioxidant protection of the organ of Corti. Conversely, the protection of the cochlea with antioxidants ameliorates the ototoxicity by cisplatin. The ototoxicity produced by cisplatin call be reversible or persistent, depending on the age of the patient, cumulative doses, number of chemotherapy cycles, history of noise exposure, and deteriorating renal function. We have obtained in rats an ototoxic chart utilizing cisplatin (10 mg/kg body weight injected intraperitoneally, once only). Together with this treatment, the animals were treated with melatonin in the drinking water (10 mg/L) or injected subcutaneously (250 mu g), and with an antioxidant mixture, injected subcutaneously, composed of 0.25 mg alpha-tocopherol acid succinate, 3 mg ascorbic acid, 1 mg glutathione, and 60 mg N-acetylcysteine. The distortion product otoacoustic emissions were determined for a prolonged period of time for each animal. The ototoxicity produced by cisplatin was maximal from days 7 to 10 post-treatment, returning to normal values in a month. When melatonin and the antioxidant mixture were present, the recovery was between days 10 and 15 post-treatment, independent of the means of administration of the pineal product. We conclude that the ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 82 条
[1]   Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy [J].
Allen, GC ;
Tiu, C ;
Koike, K ;
Ritchey, AK ;
Kurs-Lasky, M ;
Wax, MK .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1998, 118 (05) :584-588
[2]  
AOKI E, 1991, BRAIN RES, V559, P159
[3]  
BECK A, 1992, HNO, V40, P123
[4]   Circadian variations in the rat serum total antioxidant status: Correlation with melatonin levels [J].
Benot, S ;
Molinero, P ;
Soutto, M ;
Goberna, R ;
Guerrero, JM .
JOURNAL OF PINEAL RESEARCH, 1998, 25 (01) :1-4
[5]   MELATONIN AND OTHER SEROTONIN DERIVATIVES IN THE GUINEA-PIG MEMBRANOUS COCHLEA [J].
BIESALSKI, HK ;
WELKER, HA ;
THALMANN, R ;
VOLLRATH, L .
NEUROSCIENCE LETTERS, 1988, 91 (01) :41-46
[6]   Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer [J].
Bokemeyer, C ;
Berger, CC ;
Hartmann, JT ;
Kollmannsberger, C ;
Schmoll, HJ ;
Kuczyk, MA ;
Kanz, L .
BRITISH JOURNAL OF CANCER, 1998, 77 (08) :1355-1362
[7]   BASAL NITRIC-OXIDE PRODUCTION IN REGULATION OF COCHLEAR BLOOD-FLOW [J].
BRECHTELSBAUER, PB ;
NUTTALL, AL ;
MILLER, JM .
HEARING RESEARCH, 1994, 77 (1-2) :38-42
[8]   OTOTOXICITY ASSOCIATED WITH SALICYLATES - A BRIEF REVIEW [J].
BRIEN, JA .
DRUG SAFETY, 1993, 9 (02) :143-148
[9]   D-Methionine provides excellent protection from cisplatin ototoxicity in the rat [J].
Campbell, KCM ;
Rybak, LP ;
Meech, RP ;
Hughes, L .
HEARING RESEARCH, 1996, 102 (1-2) :90-98
[10]   Effects of superoxide dismutase and U74389G on acute trimethyltin-induced cochlear dysfunction [J].
Clerici, WJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 136 (02) :236-242